A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo.
暂无分享,去创建一个
Victor C Yang | V. Yang | Allan E David | Adam J. Cole | Beata Chertok | Allan E. David | Y. Park | Adam J Cole | Yoon Shin Park | Beata Chertok
[1] C. Driscoll,et al. Magnetic targeting of microspheres in blood flow. , 1984, Microvascular research.
[2] J. Laterra,et al. Endothelial differentiation in intracerebral and subcutaneous experimental gliomas , 1994, Brain Research.
[3] Q. Pankhurst,et al. Applications of magnetic nanoparticles in biomedicine , 2003 .
[4] Ralph Weissleder,et al. Multifunctional magnetic nanoparticles for targeted imaging and therapy. , 2008, Advanced drug delivery reviews.
[5] Igor Katsyv,et al. Experimental approaches for the treatment of malignant gliomas. , 2010, Pharmacology & therapeutics.
[6] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[7] Yongzhuo Huang,et al. Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[8] A P Pathak,et al. MR‐derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis , 2001, Magnetic resonance in medicine.
[9] J. Kreuter,et al. Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles , 1999, Pharmaceutical Research.
[10] J. Dobson. Magnetic nanoparticles for drug delivery , 2006 .
[11] Christian Bergemann,et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. , 2008, Biomaterials.
[12] K. Geiger,et al. Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles , 2004, International journal of cancer.
[13] T. Weyh,et al. Design and Evaluation of Magnetic Fields for Nanoparticle Drug Targeting in Cancer , 2007, IEEE Transactions on Nanotechnology.
[14] C. Alexiou,et al. A High Field Gradient Magnet for Magnetic Drug Targeting , 2006, IEEE Transactions on Applied Superconductivity.
[15] M. Garwood,et al. Imaging blood flow in brain tumors using arterial spin labeling , 2000, Magnetic resonance in medicine.
[16] James L. McGrath,et al. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. , 2009, Biomaterials.
[17] F. Stenger,et al. Control of aggregation in production and handling of nanoparticles , 2005 .
[18] Victor C Yang,et al. Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. , 2010, Biomaterials.
[19] C. Bárcena,et al. APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE , 2003 .
[20] Renwei Mei,et al. Shear lift force on spherical bubbles , 1994 .
[21] B. Moffat,et al. Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking. , 2009, Biomaterials.
[22] P A Voltairas,et al. Hydrodynamics of magnetic drug targeting. , 2002, Journal of biomechanics.
[23] M. Menger,et al. Vascular Microenvironment in Gliomas , 2000, Journal of Neuro-Oncology.
[24] Wang Shi-gang,et al. Hydrodynamic modeling of ferrofluid flow in magnetic targeting drug delivery , 2008 .
[25] P Reichardt,et al. Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. , 1996, Cancer research.
[26] V. Yang,et al. Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers. , 2011, Biomaterials.